Ana Catarina Pinto

Ana Catarina Pinto is a seasoned medical professional currently serving as the Medical Director for DU Oncology at Merck KGaA in Darmstadt, Germany, since May 2024. Pinto also contributes as an Advisory Board Member at Genotrial and serves on the Board of Exogenus Therapeutics. Prior roles include Director of Clinical Development at Pierre Fabre Group and Immatics, and ESMO Officer at the European Society for Medical Oncology, providing expertise in various oncology therapeutic areas. The medical experience is complemented by a comprehensive educational background, including an MD from Universidade do Porto and multiple qualifications in clinical oncology, pharmaceutical industry, and drug design.